Increased Langerhans cell accumulation after mycobacterial stimuli

Histopathology

Volumn 51, Issue 5, 2007, Pages 649-656

  Miranda, A ^a,b   Amadeu, T P ^b   Schueler, G ^a   Alvarenga, F B F ^b   Duppre N ^a   Ferreira, H ^a   Nery, J A C ^a   Sarno, E N ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Dendritic cells; Infection; Langerhans cells; Leprosy; Mycobacterium leprae

Indexed keywords

HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; T6 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DERMIS; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; LANGERHANS CELL; LEPROMIN TEST; LEPROSY; MULTIBACILLARY LEPROSY; MYCOBACTERIUM LEPRAE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CELL; TUBERCULIN TEST;

ANTIGENS, CD1; HLA-DR ANTIGENS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LANGERHANS CELLS; LEPROSY, LEPROMATOUS; MYCOBACTERIUM LEPRAE; SKIN;

MYCOBACTERIUM LEPRAE;

EID: 35348897245     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02848.x     Document Type: Article

References (23)

1. Sampaio EP, Sarno EN. Expression and cytokine secretion in the states of immune reactivation in leprosy. Braz. J. Med. Biol. Res. 1998 31 69 76.
2. Sieling PA, Jullien D, Dahlem M et al. CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity. J. Immunol. 1999 162 1851 1858.
3. Martin LH, Calabi F, Milstein C. Isolation of CD1 genes: a family of major histocompatibility complex-related differentiation antigens. Proc. Natl Acad. Sci. U.S.A. 1986 83 9154 9158.
4. Porcelli SA, Modlin RL. CD1 and the expanding universe of T cell antigens. J. Immunol. 1995 155 3709 3710.
5. Zeng Z, Castano AR, Segelke BW, Stura EA, Peterson PA, Wilson IA. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 1997 277 339 345.
6. Prigozy TI, Sieling PA, Clemens D et al. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 1997 6 187 197.
7. Hunger RE, Sieling PA, Ochoa MT et al. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J. Clin. Invest. 2004 113 701 708.
8. Koch S, Kohl K, Klein E, von Bubnoff D, Bieber T. Skin homing of Langerhans cell precursors: adhesion, chemotaxis, and migration. J. Allergy Clin. Immunol. 2006 117 163 168.
9. Steinman RM, Germain RN. Antigen presentation and related immunological aspects of HIV-1 vaccines. AIDS 1998 12 (Suppl. A S97 S112.
10. Aberer W, Schuler G, Stingl G, Honigsmann H, Wolff K. Ultraviolet light depletes surface markers of Langerhans cells. J. Invest. Dermatol. 1981 76 202 210.
11. Cestari TF, Kripke ML, Baptista PL, Bakos L, Bucana CD. Ultraviolet radiation decreases the granulomatous response to lepromin in humans. J. Invest. Dermatol. 1995 105 8 13.
12. Berthier-Vergnes O, Bermond F, Flacher V, Massacrier C, Schmitt D, Peguet-Navarro J. TNF-alpha enhances phenotypic and functional maturation of human epidermal Langerhans cells and induces IL-12 p40 and IP-10/CXCL-10 production. FEBS Lett. 2005 579 3660 3668.
13. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int. J. Lepr. Other Mycobact. Dis. 1966 34 255 273.
14. Arnoldi J, Gerdes J, Flad HD. Immunohistologic assessment of cytokine production of infiltrating cells in various forms of leprosy. Am. J. Pathol. 1990 137 749 753.
15. Liu JH, Shi YF, Kong QY, Yang LH, Li WZ, Ye GY. Observations of Langerhans' cells in leprosy using monoclonal antibody OKT6. Int. J. Lepr. Other Mycobact. Dis. 1984 52 524 526.
16. Rosat JP, Grant EP, Beckman EM et al. CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. J. Immunol. 1999 162 366 371.
17. Ludewig B, Graf D, Gelderblom HR, Becker Y, Kroczek RA, Pauli G. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but strongly enhanced by interleukin-10. Eur. J. Immunol. 1995 25 1943 1950.
18. Kaplan G, Nusrat A, Witmer MD, Nath I, Cohn ZA. Distribution and turnover of Langerhans cells during delayed immune responses in human skin. J. Exp. Med. 1987 165 763 776.
19. Kupper TS, Fuhlbrigge RC. Immune surveillance in the skin: mechanisms and clinical consequences. Nat. Rev. Immunol. 2004 4 211 222.
20. Khanolkar-Young S, Rayment N, Brickell PM et al. Tumour necrosis factor-alpha (TNF-alpha) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions. Clin. Exp. Immunol. 1995 99 196 202.
21. Moraes MO, Sampaio EP, Nery JA, Saraiva BC, Alvarenga FB, Sarno EN. Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient. Br. J. Dermatol. 2001 144 175 181.
22. Arends AM, Tapia FJ, Dittmar GC, Mosca W, Valecillos L, Convit J. Immunocytochemical characterization of immune cells in lesions of American cutaneous leishmaniasis using novel T cell markers. Acta Trop. (Amsterdam) 1991 49 271 280.
23. Kaplan G, Laal S, Sheftel G et al. The nature and kinetics of a delayed immune response to purified protein derivative of tuberculin in the skin of lepromatous leprosy patients. J. Exp. Med. 1988 168 1811 1824.